• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镭致骨癌:犬类剂量反应可解释小鼠和人类的数据。

Bone cancer from radium: canine dose response explains data for mice and humans.

作者信息

Raabe O G, Book S A, Parks N J

出版信息

Science. 1980 Apr 4;208(4439):61-4. doi: 10.1126/science.7361106.

DOI:10.1126/science.7361106
PMID:7361106
Abstract

Analysis of lifetime studies of 243 beagles with skeletal burdens of radium-226 shows that the distribution of bone cancers clusters about a linear function of the logarithms of radiation dose rate to the skeleton and time from exposure until death. Similar relations displaced by species-dependent response ratios also provide satisfactory descriptions of the reported data on deaths from primary bone cancers in people and mice exposed to radium-226. The median cumulative doses (or times) leading to death from bone tumors are 2.9 times larger for dogs than for mice and 3.6 times larger for people than for dogs. These response ratios are well correlated with the normal life expectancies. The cumulative radiation dose required to give significant risk of bone cancer is found to be much less at lower dose rates than at higher rates, but the time required for the tumors to be manifested is longer. At low dose rates, this time exceeds the normal life-span and appears as a practical threshold, which for bone cancer is estimated to occur at an average cumulative radiation dose to the skeleton of about 50 to 110 rads for the three species.

摘要

对243只镭 - 226骨骼负荷的比格犬进行的终生研究分析表明,骨癌的分布集中在骨骼辐射剂量率对数与从暴露到死亡的时间的线性函数周围。由物种依赖反应比所偏移的类似关系,也为暴露于镭 - 226的人和小鼠原发性骨癌死亡的报告数据提供了令人满意的描述。导致骨肿瘤死亡的中位累积剂量(或时间),狗比小鼠大2.9倍,人比狗大3.6倍。这些反应比与正常预期寿命密切相关。发现给予显著骨癌风险所需的累积辐射剂量在低剂量率下比高剂量率下要少得多,但肿瘤出现所需的时间更长。在低剂量率下,这段时间超过了正常寿命,表现为一个实际阈值,对于骨癌,估计这一阈值发生时,三种物种骨骼的平均累积辐射剂量约为50至110拉德。

相似文献

1
Bone cancer from radium: canine dose response explains data for mice and humans.镭致骨癌:犬类剂量反应可解释小鼠和人类的数据。
Science. 1980 Apr 4;208(4439):61-4. doi: 10.1126/science.7361106.
2
Lifetime bone cancer dose-response relationships in beagles and people from skeletal burdens of 226Ra and 90Sr.根据比格犬和人类体内226镭和90锶的骨骼负荷得出的终生骨癌剂量反应关系。
Health Phys. 1983;44 Suppl 1:33-48. doi: 10.1097/00004032-198306001-00002.
3
Interspecies scaling of risk for radiation-induced bone cancer.辐射诱发骨癌风险的种间缩放
Int J Radiat Biol. 1990 May;57(5):1047-61. doi: 10.1080/09553009014551151.
4
Lifetime studies of 226Ra and 90Sr toxicity in beagles--a status report.
Radiat Res. 1981 Jun;86(3):515-28.
5
Scaling of fatal cancer risks from laboratory animals to man.从实验动物到人类的致命癌症风险缩放。
Health Phys. 1989;57 Suppl 1:419-32. doi: 10.1097/00004032-198907001-00059.
6
Dose-response relationships for bone tumors in beagles exposed to 226Ra and 90Sr.
Health Phys. 1981 Jun;40(6):863-80. doi: 10.1097/00004032-198106000-00009.
7
Mechanistic models of bone cancer induction by radium and plutonium in animals compared to humans.
Radiat Prot Dosimetry. 2006;122(1-4):340-4. doi: 10.1093/rpd/ncl513. Epub 2006 Dec 13.
8
Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.体内沉积放射性核素与外照射对人类致癌作用的定量比较。
Int J Radiat Biol. 2003 Jan;79(1):1-13.
9
Concerning the health effects of internally deposited radionuclides.关于体内沉积放射性核素对健康的影响。
Health Phys. 2010 Mar;98(3):515-36. doi: 10.1097/HP.0b013e3181c20e25.
10
Radium in drinking water and risk of bone cancer in Ontario youths: a second study and combined analysis.安大略省青少年饮用水中的镭与骨癌风险:第二项研究及综合分析
Occup Environ Med. 1996 May;53(5):305-11. doi: 10.1136/oem.53.5.305.

引用本文的文献

1
Radiation exposure and cancer: a simpler view of Three Mile Island.辐射暴露与癌症:对三里岛事件的更简单看法。
Environ Health Perspect. 1997 Jun;105(6):566. doi: 10.1289/ehp.105-1470082.
2
Iodine-125 labeled phenylphosphonic acid: a new radiopharmaceutical for long-term investigations of the skeleton.
Skeletal Radiol. 1982 Jan;7(4):233-7. doi: 10.1007/BF00361978.